1
|
Fuster MM. Integrating electromagnetic cancer stress with immunotherapy: a therapeutic paradigm. Front Oncol 2024; 14:1417621. [PMID: 39165679 PMCID: PMC11333800 DOI: 10.3389/fonc.2024.1417621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2024] [Accepted: 07/11/2024] [Indexed: 08/22/2024] Open
Abstract
An array of published cell-based and small animal studies have demonstrated a variety of exposures of cancer cells or experimental carcinomas to electromagnetic (EM) wave platforms that are non-ionizing and non-thermal. Overall effects appear to be inhibitory, inducing cancer cell stress or death as well as inhibition in tumor growth in experimental models. A variety of physical input variables, including discrete frequencies, amplitudes, and exposure times, have been tested, but drawing methodologic rationale and mechanistic conclusions across studies is challenging. Nevertheless, outputs such as tumor cytotoxicity, apoptosis, tumor membrane electroporation and leak, and reactive oxygen species generation are intriguing. Early EM platforms in humans employ pulsed electric fields applied either externally or using interventional tumor contact to induce tumor cell electroporation with stromal, vascular, and immunologic sparing. It is also possible that direct or external exposures to non-thermal EM waves or pulsed magnetic fields may generate electromotive forces to engage with unique tumor cell properties, including tumor glycocalyx to induce carcinoma membrane disruption and stress, providing novel avenues to augment tumor antigen release, cross-presentation by tumor-resident immune cells, and anti-tumor immunity. Integration with existing checkpoint inhibitor strategies to boost immunotherapeutic effects in carcinomas may also emerge as a broadly effective strategy, but little has been considered or tested in this area. Unlike the use of chemo/radiation and/or targeted therapies in cancer, EM platforms may allow for the survival of tumor-associated immunologic cells, including naïve and sensitized anti-tumor T cells. Moreover, EM-induced cancer cell stress and apoptosis may potentiate endogenous tumor antigen-specific anti-tumor immunity. Clinical studies examining a few of these combined EM-platform approaches are in their infancy, and a greater thrust in research (including basic, clinical, and translational work) in understanding how EM platforms may integrate with immunotherapy will be critical in driving advances in cancer outcomes under this promising combination.
Collapse
Affiliation(s)
- Mark M. Fuster
- Research Service, VA San Diego Healthcare System, San Diego, CA, United States
- Pulmonary & Critical Care Division, University of California, San Diego, San Diego, CA, United States
- Department of Cellular & Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, San Diego, CA, United States
- Veterans Medical Research Foundation, San Diego, CA, United States
| |
Collapse
|
2
|
Gu H, Fu Y, Yu B, Luo L, Kang D, Xie M, Jing Y, Chen Q, Zhang X, Lai J, Guan F, Forsman H, Shi J, Yang L, Lei J, Du X, Zhang X, Liu C. Ultra-high static magnetic fields cause immunosuppression through disrupting B-cell peripheral differentiation and negatively regulating BCR signaling. MedComm (Beijing) 2023; 4:e379. [PMID: 37789963 PMCID: PMC10542999 DOI: 10.1002/mco2.379] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2023] [Revised: 08/16/2023] [Accepted: 08/24/2023] [Indexed: 10/05/2023] Open
Abstract
To increase the imaging resolution and detection capability, the field strength of static magnetic fields (SMFs) in magnetic resonance imaging (MRI) has significantly increased in the past few decades. However, research on the side effects of high magnetic field is still very inadequate and the effects of SMF above 1 T (Tesla) on B cells have never been reported. Here, we show that 33.0 T ultra-high SMF exposure causes immunosuppression and disrupts B cell differentiation and signaling. 33.0 T SMF treatment resulted in disturbance of B cell peripheral differentiation and antibody secretion and reduced the expression of IgM on B cell membrane, and these might be intensity dependent. In addition, mice exposed to 33.0 T SMF showed inhibition on early activation of B cells, including B cell spreading, B cell receptor clustering and signalosome recruitment, and depression of both positive and negative molecules in the proximal BCR signaling, as well as impaired actin reorganization. Sequencing and gene enrichment analysis showed that SMF stimulation also affects splenic B cells' transcriptome and metabolic pathways. Therefore, in the clinical application of MRI, we should consider the influence of SMF on the immune system and choose the optimal intensity for treatment.
Collapse
Affiliation(s)
- Heng Gu
- Department of Pathogen BiologySchool of Basic MedicineTongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonostic Infectious DiseaseHuazhong University of Science and TechnologyWuhanChina
| | - Yufan Fu
- Department of Pathogen BiologySchool of Basic MedicineTongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonostic Infectious DiseaseHuazhong University of Science and TechnologyWuhanChina
| | - Biao Yu
- High Magnetic Field LaboratoryHefei Institutes of Physical ScienceChinese Academy of SciencesHefeiAnhuiChina
| | - Li Luo
- Department of Pathogen BiologySchool of Basic MedicineTongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonostic Infectious DiseaseHuazhong University of Science and TechnologyWuhanChina
| | - Danqing Kang
- Department of Pathogen BiologySchool of Basic MedicineTongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonostic Infectious DiseaseHuazhong University of Science and TechnologyWuhanChina
| | - Miaomiao Xie
- Department of Pathogen BiologySchool of Basic MedicineTongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonostic Infectious DiseaseHuazhong University of Science and TechnologyWuhanChina
| | - Yukai Jing
- Department of Pathogen BiologySchool of Basic MedicineTongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonostic Infectious DiseaseHuazhong University of Science and TechnologyWuhanChina
| | - Qiuyue Chen
- Department of Pathogen BiologySchool of Basic MedicineTongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonostic Infectious DiseaseHuazhong University of Science and TechnologyWuhanChina
| | - Xin Zhang
- GeneMind Biosciences Company LimitedShenzhenChina
| | - Juan Lai
- GeneMind Biosciences Company LimitedShenzhenChina
| | - Fei Guan
- Department of Pathogen BiologySchool of Basic MedicineTongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonostic Infectious DiseaseHuazhong University of Science and TechnologyWuhanChina
| | - Huamei Forsman
- Department of Rheumatology and Inflammation ResearchInstitute of MedicineSahlgrenska AcademyUniversity of GothenburgGoteborgSweden
| | - Junming Shi
- Department of Pathogen BiologySchool of Basic MedicineTongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonostic Infectious DiseaseHuazhong University of Science and TechnologyWuhanChina
| | - Lu Yang
- Department of Pathogen BiologySchool of Basic MedicineTongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonostic Infectious DiseaseHuazhong University of Science and TechnologyWuhanChina
| | - Jiahui Lei
- Department of Pathogen BiologySchool of Basic MedicineTongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonostic Infectious DiseaseHuazhong University of Science and TechnologyWuhanChina
| | - Xingrong Du
- Shanghai Key Laboratory of Metabolic Remodeling and HealthInstitute of Metabolism and Integrative BiologyFudan UniversityShanghaiChina
| | - Xin Zhang
- High Magnetic Field LaboratoryHefei Institutes of Physical ScienceChinese Academy of SciencesHefeiAnhuiChina
- Institutes of Physical Science and Information TechnologyAnhui UniversityHefeiAnhuiChina
| | - Chaohong Liu
- Department of Pathogen BiologySchool of Basic MedicineTongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonostic Infectious DiseaseHuazhong University of Science and TechnologyWuhanChina
| |
Collapse
|
3
|
Peng Z, Zhang W, Zhang X, Mao J, Zhang Q, Zhao W, Zhang S, Xie J. Recent advances in analysis of capsaicin and its effects on metabolic pathways by mass spectrometry. Front Nutr 2023; 10:1227517. [PMID: 37575327 PMCID: PMC10419207 DOI: 10.3389/fnut.2023.1227517] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2023] [Accepted: 07/12/2023] [Indexed: 08/15/2023] Open
Abstract
Capsaicin is the main food active component in Capsicum that has gained considerable attention due to its broad biological activities, including antioxidation, anti-inflammation, anti-tumor, weight regulation, cardiac protection, anti-calculi, and diurnal-circadian regulation. The potent biological effects of capsaicin are intimately related to metabolic pathways such as lipid metabolism, energy metabolism, and antioxidant stress. Mass spectrometry (MS) has emerged as an effective tool for deciphering the mechanisms underlying capsaicin metabolism and its biological impacts. However, it remains challenging to accurately identify and quantify capsaicin and its self-metabolites in complex food and biological samples, and to integrate multi-omics data generated from MS. In this work, we summarized recent advances in the detection of capsaicin and its self-metabolites using MS and discussed the relevant MS-based studies of metabolic pathways. Furthermore, we discussed current issues and future directions in this field. In-depth studies of capsaicin metabolism and its physiological functions based on MS is anticipated to yield new insights and methods for preventing and treating a wide range of diseases.
Collapse
Affiliation(s)
- Zifang Peng
- College of Chemistry, Zhengzhou University, Zhengzhou, Henan, China
| | - Wenfen Zhang
- College of Chemistry, Zhengzhou University, Zhengzhou, Henan, China
- Zhengzhou Tobacco Research Institute of CNTC, Zhengzhou, Henan, China
| | - Xu Zhang
- School of Ecology and Environment, Zhengzhou University, Zhengzhou, Henan, China
| | - Jian Mao
- Zhengzhou Tobacco Research Institute of CNTC, Zhengzhou, Henan, China
- Food Laboratory of Zhongyuan, Flavor Science Research Center of Zhengzhou University, Luohe, Henan, China
| | - Qidong Zhang
- Zhengzhou Tobacco Research Institute of CNTC, Zhengzhou, Henan, China
- Food Laboratory of Zhongyuan, Flavor Science Research Center of Zhengzhou University, Luohe, Henan, China
| | - Wuduo Zhao
- College of Chemistry, Zhengzhou University, Zhengzhou, Henan, China
| | - Shusheng Zhang
- College of Chemistry, Zhengzhou University, Zhengzhou, Henan, China
- Food Laboratory of Zhongyuan, Flavor Science Research Center of Zhengzhou University, Luohe, Henan, China
| | - Jianping Xie
- Zhengzhou Tobacco Research Institute of CNTC, Zhengzhou, Henan, China
- Food Laboratory of Zhongyuan, Flavor Science Research Center of Zhengzhou University, Luohe, Henan, China
| |
Collapse
|
4
|
Shaw P, Vanraes P, Kumar N, Bogaerts A. Possible Synergies of Nanomaterial-Assisted Tissue Regeneration in Plasma Medicine: Mechanisms and Safety Concerns. NANOMATERIALS (BASEL, SWITZERLAND) 2022; 12:3397. [PMID: 36234523 PMCID: PMC9565759 DOI: 10.3390/nano12193397] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 08/15/2022] [Revised: 09/05/2022] [Accepted: 09/06/2022] [Indexed: 06/16/2023]
Abstract
Cold atmospheric plasma and nanomedicine originally emerged as individual domains, but are increasingly applied in combination with each other. Most research is performed in the context of cancer treatment, with only little focus yet on the possible synergies. Many questions remain on the potential of this promising hybrid technology, particularly regarding regenerative medicine and tissue engineering. In this perspective article, we therefore start from the fundamental mechanisms in the individual technologies, in order to envision possible synergies for wound healing and tissue recovery, as well as research strategies to discover and optimize them. Among these strategies, we demonstrate how cold plasmas and nanomaterials can enhance each other's strengths and overcome each other's limitations. The parallels with cancer research, biotechnology and plasma surface modification further serve as inspiration for the envisioned synergies in tissue regeneration. The discovery and optimization of synergies may also be realized based on a profound understanding of the underlying redox- and field-related biological processes. Finally, we emphasize the toxicity concerns in plasma and nanomedicine, which may be partly remediated by their combination, but also partly amplified. A widespread use of standardized protocols and materials is therefore strongly recommended, to ensure both a fast and safe clinical implementation.
Collapse
Affiliation(s)
- Priyanka Shaw
- Research Group PLASMANT, Department of Chemistry, University of Antwerp, 2610 Antwerp, Belgium
| | - Patrick Vanraes
- Research Group PLASMANT, Department of Chemistry, University of Antwerp, 2610 Antwerp, Belgium
| | - Naresh Kumar
- Department of Medical Devices, National Institute of Pharmaceutical Education and Research, Guwahati 781125, Assam, India
| | - Annemie Bogaerts
- Research Group PLASMANT, Department of Chemistry, University of Antwerp, 2610 Antwerp, Belgium
| |
Collapse
|
5
|
Tuszynski JA, Costa F. Low-energy amplitude-modulated radiofrequency electromagnetic fields as a systemic treatment for cancer: Review and proposed mechanisms of action. FRONTIERS IN MEDICAL TECHNOLOGY 2022; 4:869155. [PMID: 36157082 PMCID: PMC9498185 DOI: 10.3389/fmedt.2022.869155] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2022] [Accepted: 08/19/2022] [Indexed: 11/13/2022] Open
Abstract
Exposure to Low-Energy Amplitude-Modulated Radiofrequency Electromagnetic Fields (LEAMRFEMF) represents a new treatment option for patients with advanced hepatocellular carcinoma (AHCC). We focus on two medical devices that modulate the amplitude of a 27.12 MHz carrier wave to generate envelope waves in the low Hz to kHz range. Each provides systemic exposure to LEAMRFEMF via an intrabuccal antenna. This technology differs from so-called Tumour Treating Fields because it uses different frequency ranges, uses electromagnetic rather than electric fields, and delivers energy systemically rather than locally. The AutemDev also deploys patient-specific frequencies. LEAMRFEMF devices use 100-fold less power than mobile phones and have no thermal effects on tissue. Tumour type-specific or patient-specific treatment frequencies can be derived by measuring haemodynamic changes induced by exposure to LEAMRFEMF. These specific frequencies inhibited growth of human cancer cell lines in vitro and in mouse xenograft models. In uncontrolled prospective clinical trials in patients with AHCC, minorities of patients experienced complete or partial tumour responses. Pooled comparisons showed enhanced overall survival in treated patients compared to historical controls. Mild transient somnolence was the only notable treatment-related adverse event. We hypothesize that intracellular oscillations of charged macromolecules and ion flows couple resonantly with LEAMRFEMF. This resonant coupling appears to disrupt cell division and subcellular trafficking of mitochondria. We provide an estimate of the contribution of the electromagnetic effects to the overall energy balance of an exposed cell by calculating the power delivered to the cell, and the energy dissipated through the cell due to EMF induction of ionic flows along microtubules. We then compare this with total cellular metabolic energy production and conclude that energy delivered by LEAMRFEMF may provide a beneficial shift in cancer cell metabolism away from aberrant glycolysis. Further clinical research may confirm that LEAMRFEMF has therapeutic value in AHCC.
Collapse
Affiliation(s)
- Jack A. Tuszynski
- Division of Experimental Oncology, Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
- Dipartimento di Ingegneria Meccanica e Aerospaziale, Politecnico di Torino, Turin, Italy
- Autem Therapeutics, Hanover, NH, United States
- Correspondence: Jack A. Tuszynski
| | - Frederico Costa
- Autem Therapeutics, Hanover, NH, United States
- Oncology Department, Hospital Sírio-Libanês, São Paulo, Brazil
| |
Collapse
|
6
|
Abstract
The potential therapeutic uses of electromagnetic fields (EMF), part of the nonionizing radiation spectrum, increase with time. Among them, those considering the potential antitumor effects exerted by the Magnetic Fields (MFs), part of the EMF entity, have gained more and more interest. A recent review on this subject reports the MFs' effect on apoptosis of tumor cells as one of the most important breakthroughs. Apoptosis is considered a key mechanism regulating the genetic stability of cells and as such is considered of fundamental importance in cancer initiation and development. According to an atomic/sub-atomic analysis, based on quantum physics, of the complexity of biological life and the role played by oxygen and its radicals in cancer biology, a possible biophysical mechanism is described. The mechanism considers the influence of MFs on apoptosis through an effect on electron spin that is able to increase reactive oxygen species (ROS) concentration. Impacting on the delicate balance between ROS production and ROS elimination in tumor cells is considered a promising cancer therapy, affecting different biological processes, such as apoptosis and metastasis. An analysis in the literature, which allows correlation between MFs exposure characteristics and their influence on apoptosis and ROS concentration, supports the validity of the mechanism.
Collapse
Affiliation(s)
- Santi Tofani
- Department of Medical Physics, Ivrea Hospital - ASL Torino Nord-Ovest TO4, Ivrea Torino, Italy.,Department of Public Health Science, School of Medicine, University of Turin, Ivrea Torino, Italy
| |
Collapse
|
7
|
Shaev IA, Novikov VV, Yablokova EV, Fesenko EE. A Brief Review of the Current State of Research on the Biological Effects of Weak Magnetic Fields. Biophysics (Nagoya-shi) 2022. [DOI: 10.1134/s0006350922020191] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
8
|
Golovin YI, Golovin DY, Vlasova KY, Veselov MM, Usvaliev AD, Kabanov AV, Klyachko NL. Non-Heating Alternating Magnetic Field Nanomechanical Stimulation of Biomolecule Structures via Magnetic Nanoparticles as the Basis for Future Low-Toxic Biomedical Applications. NANOMATERIALS (BASEL, SWITZERLAND) 2021; 11:2255. [PMID: 34578570 PMCID: PMC8470408 DOI: 10.3390/nano11092255] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/31/2021] [Revised: 08/23/2021] [Accepted: 08/24/2021] [Indexed: 12/13/2022]
Abstract
The review discusses the theoretical, experimental and toxicological aspects of the prospective biomedical application of functionalized magnetic nanoparticles (MNPs) activated by a low frequency non-heating alternating magnetic field (AMF). In this approach, known as nano-magnetomechanical activation (NMMA), the MNPs are used as mediators that localize and apply force to such target biomolecular structures as enzyme molecules, transport vesicles, cell organelles, etc., without significant heating. It is shown that NMMA can become a biophysical platform for a family of therapy methods including the addressed delivery and controlled release of therapeutic agents from transport nanomodules, as well as selective molecular nanoscale localized drugless nanomechanical impacts. It is characterized by low system biochemical and electromagnetic toxicity. A technique of 3D scanning of the NMMA region with the size of several mm to several cm over object internals has been described.
Collapse
Affiliation(s)
- Yuri I. Golovin
- Institute “Nanotechnology and Nanomaterials”, G.R. Derzhavin Tambov State University, 392000 Tambov, Russia; (Y.I.G.); (D.Y.G.)
- Department of Chemical Enzymology, School of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia; (K.Y.V.); (M.M.V.); (A.D.U.); (A.V.K.)
| | - Dmitry Yu. Golovin
- Institute “Nanotechnology and Nanomaterials”, G.R. Derzhavin Tambov State University, 392000 Tambov, Russia; (Y.I.G.); (D.Y.G.)
| | - Ksenia Yu. Vlasova
- Department of Chemical Enzymology, School of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia; (K.Y.V.); (M.M.V.); (A.D.U.); (A.V.K.)
| | - Maxim M. Veselov
- Department of Chemical Enzymology, School of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia; (K.Y.V.); (M.M.V.); (A.D.U.); (A.V.K.)
| | - Azizbek D. Usvaliev
- Department of Chemical Enzymology, School of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia; (K.Y.V.); (M.M.V.); (A.D.U.); (A.V.K.)
| | - Alexander V. Kabanov
- Department of Chemical Enzymology, School of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia; (K.Y.V.); (M.M.V.); (A.D.U.); (A.V.K.)
- Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| | - Natalia L. Klyachko
- Institute “Nanotechnology and Nanomaterials”, G.R. Derzhavin Tambov State University, 392000 Tambov, Russia; (Y.I.G.); (D.Y.G.)
- Department of Chemical Enzymology, School of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia; (K.Y.V.); (M.M.V.); (A.D.U.); (A.V.K.)
- Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
| |
Collapse
|
9
|
Orel VE, Krotevych M, Dasyukevich O, Rykhalskyi O, Syvak L, Tsvir H, Tsvir D, Garmanchuk L, Orel VВ, Sheina I, Rybka V, Shults NV, Suzuki YJ, Gychka SG. Effects induced by a 50 Hz electromagnetic field and doxorubicin on Walker-256 carcinosarcoma growth and hepatic redox state in rats. Electromagn Biol Med 2021; 40:475-487. [PMID: 34392747 DOI: 10.1080/15368378.2021.1958342] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
We compare the effects of an extremely low-frequency electromagnetic field (EMF) with the chemotherapeutic agent doxorubicin (DOX) on tumor growth and the hepatic redox state in Walker-256 carcinosarcoma-bearing rats. Animals were divided into five groups with one control (no tumor) and four tumor-bearing groups: no treatment, DOX, DOX combined with EMF and EMF. While DOX and DOX + EMF provided greater inhibition of tumor growth, treatment with EMF alone resulted in some level of antitumor effect (p < .05). Superoxide dismutase, catalase activity and glutathione content were significantly decreased in the liver of tumor-bearing animals as compared with the control group (p < .05). The decreases in antioxidant defenses accompanied histological findings of suspected liver damage. However, hepatic levels of thiobarbituric acid reactive substances, an indicator of lipid peroxidation, were three times lower in EMF and DOX + EMF groups than in no treatment and DOX (p < .05). EMF and DOX + EMF showed significantly lower activity of serum ALT than DOX alone (p < .05). These results indicate that EMF treatment can inhibit tumor growth, causing less pronounced oxidative stress damage to the liver. Therefore, EMF can be used as a therapeutic strategy to influence the hepatic redox state and combat cancer with reduced side-effects.
Collapse
Affiliation(s)
- Valerii E Orel
- Medical Physics and Bioengineering Research Laboratory, National Cancer Institute, Kyiv, Ukraine.,Biomedical Engineering Department, NTUU "Igor Sikorsky KPI", Kyiv, Ukraine
| | - Mykhailo Krotevych
- Research Department of the Pathological Anatomy, National Cancer Institute, Kyiv, Ukraine
| | - Olga Dasyukevich
- Medical Physics and Bioengineering Research Laboratory, National Cancer Institute, Kyiv, Ukraine
| | - Oleksandr Rykhalskyi
- Medical Physics and Bioengineering Research Laboratory, National Cancer Institute, Kyiv, Ukraine
| | - Liubov Syvak
- Research Department of Chemotherapy Solid Tumors, National Cancer Institute, Kyiv, Ukraine
| | | | - Dmytro Tsvir
- Medical Faculty, Bogomolets National Medical University, Kyiv, Ukraine
| | - Lyudmyla Garmanchuk
- Department of Biomedicine, NSC "Institute of Biology and Medicine" of the Taras Shevchenko National University of Kyiv, Kyiv, Ukraine
| | - Valerii В Orel
- Biomedical Engineering Department, NTUU "Igor Sikorsky KPI", Kyiv, Ukraine.,Research Department of Radiodiagnostics, National Cancer Institute, Kyiv, Ukraine
| | - Iryna Sheina
- Department of Medical Physics and Biomedical Nanotechnologies, V. N. Karazin Kharkiv National University, Kharkiv, Ukraine
| | - Vladyslava Rybka
- Department of Pharmacology and Physiology, Georgetown University Medical Center, Washington, DC, USA
| | - Nataliia V Shults
- Department of Medical Physics and Biomedical Nanotechnologies, V. N. Karazin Kharkiv National University, Kharkiv, Ukraine
| | - Yuichiro J Suzuki
- Department of Medical Physics and Biomedical Nanotechnologies, V. N. Karazin Kharkiv National University, Kharkiv, Ukraine
| | - Sergiy G Gychka
- Department of Pathological Anatomy 2, Bogomolets National Medical University, Kyiv, Ukraine
| |
Collapse
|